Xspray Pharma AB (publ)
SSE:XSPRAY.ST
Overview | Financials
Company Name | Xspray Pharma AB (publ) |
Symbol | XSPRAY.ST |
Currency | SEK |
Price | 44 |
Market Cap | 1,375,154,000 |
Dividend Yield | 0% |
52-week-range | 28.1 - 83.736 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Per Andersson Ph.D. |
Website | https://www.xspraypharma.com |
An error occurred while fetching data.
About Xspray Pharma AB (publ)
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD